Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous Leukemia
Karamjeet Sandhu, Vinod Pullarkat(City of Hope), Monzr Al Malki(City of Hope), Ahmed Aribi(City of Hope), Stephen J. Forman(City Of Hope National Medical Center), Sanjeet Dadwal(City Of Hope National Medical Center), Ibrahim Aldoss(City of Hope), Guido Marcucci(City of Hope), Matthew Mei(City of Hope), Amandeep Salhotra(City of Hope), Haris Ali(City of Hope), Ryotaro Nakamura(City Of Hope National Medical Center), Samer K. Khaled, Dongyun Yang(City of Hope), Joycelynne Palmer(City of Hope), David S. Snyder(City Of Hope National Medical Center), Anthony S. Stein(University of Hohenheim)
Cited by 43
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k